Abstract. Dichrocephala integrifolia is a plant widely used in folk medicine in Africa to treat central nervous diseases such as dementia. In the present study, we evaluated the effect of the leave's decoction of Dichrocephala integrifolia against D-galactose-induced neurotoxicity, oxidative stress and accelerated aging in mice. D-galactose (100 mg/ kg sc), was chronically injected daily to mice during 42 consecutive days after pretreatment with distilled water (10 ml/kg) or the decoction of D. integrifolia (35; 87.5; 175 or 350 mg/kg p.o) or vitamin C (100 mg/kg p.o). Following behavioral tasks (Open Field, Elevated Plus Maze and Morris Water Maze), animals were sacrificed on day 43 and their brains were used to evaluate some biochemical parameters of oxidative stress (malondialdehyde, nitrite oxide and reduced glutathione) and for histopathological assessments. The results of this study showed that a pretreatment of animals with the decoction of D. integrifolia at the doses of 87.5 and 175 mg/kg significantly (p˂0.05) reversed learning deficits, recall of memories and oxidative stress induced by D-galactose. The decoction of D. integrifolia also prevented neurogeneration in the dentate gyrus induced by D-galactose. These results indicated that D. integrifolia possesses neuroprotective effects against D-galactose-induced senescence, probably due to its antioxidant capacities and this can at least explain the wide use of this plant in traditional medicine in Cameroon in the prevention and treatment of dementia.

Aims: The present research was carried out to investigate the anti-inflammatory, analgesic and antipyretic potential of aqueous extract of Albizia ferruginea stem bark. Place and Duration of Study: Department of Animal Biology and Physiology (Animal Physiology Laboratory), Faculty of Sciences, University of Yaoundé I. between March 2012 and June 2016. Methods: Qualitative and quantitative phytochemical analyzes were done.The anti-inflammatory effect of the plant extract (100 and 200 mg/kg) was investigated on carrageenan, histamine, serotonin or dextran-induced paw oedema. The analgesic activity was evaluated on acetic acid-induced writhing, formalin-induced nociception, hot plate and tail immersion tests in Swiss albino mice. The antipyretic activity of A. ferruginea extract was assessed on brewer’s yeast induced pyrexia. Results: Qualitative phytochemical analysis of the AEAF revealed the presence of alkaloids, flavonoïds, phenols, saponins, tannins, glycosides, tannins and steroids. For quantitative phytochemical analysis, total flavonols represent 0.12±0.04 mg EQT/g dried extract and the total phenol content was 58.69±0.65 mg ECA/g dried extract. The total flavonoids content was 0.18±0.01mg EQT/g dried extract).The total alkaloids presented a grade of 27.45±0.14 mg EBER/g dried extract. Carrageenan, dextran, histamine and serotonin-induced inflammation were significantly inhibited by A. ferruginea’s extract (200 mg/kg), exhibiting 55.47%, 50.26%, 62.88% and 42.59% inhibition, respectively. Acetic acid-induced writhing was significantly reduced by the plant extract. The extract of Albizia ferruginea (200 mg/kg) significantly reduced the second phase of formalin test. The analgesic tests revealed that A. ferruginea had only peripheral analgesic effect. Additionally, the plant’s extract prevented brewer’s yeast-induced pyrexia in rats. Conclusion: Taken together, these results suggest that A. ferruginea’s aqueous extract has anti-inflammatory, anti-nociceptive and antipyretic properties and this strongly supports the ethnopharmacological uses.